- Report
- November 2023
- 185 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- October 2023
- 71 Pages
India
From €3477EUR$3,500USD£2,891GBP
- Report
- October 2023
- 190 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- October 2023
- 188 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- October 2023
- 82 Pages
Malaysia
From €3477EUR$3,500USD£2,891GBP
- Report
- October 2023
- 174 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- October 2023
- 190 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- August 2023
- 113 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- January 2022
- 200 Pages
Global
From €5216EUR$5,250USD£4,336GBP
€7451EUR$7,500USD£6,195GBP
- Report
- January 2022
- 60 Pages
Global
From €2747EUR$2,765USD£2,284GBP
€3924EUR$3,950USD£3,263GBP
- Report
- October 2023
- 170 Pages
Global
From €2484EUR$2,500USD£2,065GBP
- Report
- June 2023
- 168 Pages
Global
From €2484EUR$2,500USD£2,065GBP
- Report
- June 2022
- 120 Pages
Global
From €2484EUR$2,500USD£2,065GBP
- Report
- May 2022
- 120 Pages
Global
From €2484EUR$2,500USD£2,065GBP
- Report
- August 2020
- 168 Pages
Europe
From €2086EUR$2,100USD£1,735GBP
€2980EUR$3,000USD£2,478GBP
- Report
- April 2023
- 160 Pages
Global
From €5960EUR$5,999USD£4,955GBP
- Report
- November 2023
- 140 Pages
Global
From €2979EUR$2,999USD£2,477GBP
- Report
- October 2023
- 140 Pages
Global
From €2979EUR$2,999USD£2,477GBP
- Report
- June 2023
- 180 Pages
Global
From €5960EUR$5,999USD£4,955GBP
- Report
- May 2023
- 160 Pages
Global
From €5960EUR$5,999USD£4,955GBP
The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics.
The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more